Gastroenterology

  • Colorectal cancer screening
    Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001
  • Functional heartburn: An underrecognized cause of PPI-refractory symptoms
    Functional heartburn: An underrecognized cause of PPI-refractory symptoms
    Scott Gabbard, MD and Sonya Vijayvargiya,
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

    Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • Current management of Barrett esophagus and esophageal adenocarcinoma
    Current management of Barrett esophagus and esophageal adenocarcinoma
    Tavankit Singh, MD, Vedha Sanghi, MD and Prashanthi N. Thota, MD, FACG
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 724-732; DOI: https://doi.org/10.3949/ccjm.86a.18106

    Risk factors: reflux symptoms > 5 years, male sex, age > 50, white race, central obesity, and smoking.

  • Vulvar and gluteal manifestations of Crohn disease
    Anna Camille Moreno, DO, NCMP, Oluwatosin Goje, MD, MSCR, FACOG, Melissa Peck Piliang, MD, FAAD and Pelin Batur, MD, NCMP, CCD
    Cleveland Clinic Journal of Medicine October 2019, 86 (10) 645-646; DOI: https://doi.org/10.3949/ccjm.86a.19062

    Crohn disease is associated with extraintestinal manifestations in up to 45% of patients.

  • Hemorrhoids: A range of treatments
    Hemorrhoids: A range of treatments
    Turgut Bora Cengiz, MD and Emre Gorgun, MD, FACS, FASCRS
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 612-620; DOI: https://doi.org/10.3949/ccjm.86a.18079

    Each patient is unique, and with the range of options available, treatment can be individualized.

  • Colorectal cancer screening: Choosing the right test
    Gautam Mankaney, MD, Richard Andrew Sutton, DO and Carol A. Burke, MD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 385-392; DOI: https://doi.org/10.3949/ccjm.86a.17125

    The choice depends on patient preference, family history, and the likelihood of compliance.

  • Dabigatran-induced esophagitis
    Yusaku Kajihara, MD, FACP
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 303; DOI: https://doi.org/10.3949/ccjm.86a.18117

    The tablets contain tartaric acid, and if they get stuck in the esophagus, the acid leaching out can damage the mucosa.

  • Gastric outlet obstruction: A red flag, potentially manageable
    Andree H. Koop, MD, William C. Palmer, MD and Fernando F. Stancampiano, MD
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 345-353; DOI: https://doi.org/10.3949/ccjm.86a.18035

    Presume the cause to be a malignant tumor untill proven otherwise.

  • Personalizing guideline-driven cancer screening
    Gautam Mankaney, MD and Carol A. Burke, MD
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 228-230; DOI: https://doi.org/10.3949/ccjm.86a.19037

    Screening can lead to early diagnosis and prevent death from cancer, but the topic provokes controversy.

Pages